Meningococcal (Groups A, C, Y, W) Conjugate Vaccine
| Brand name | Menquadfi |
|---|---|
| Active ingredient | Meningococcal (Groups A, C, Y, W) Conjugate Vaccine |
| Strength | 0.5ML |
| Dosage form | Injection |
| Route | Intramuscular |
| Modality | Biologic |
| FDA approval | April 2020 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.